循环抗衰老αKlotho在心脏衰老中的作用
1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
概括
补充抗衰老激素α-Klotho,通过增强腹功能和减少心脏损伤,改善了老鼠的心脏功能. 这突显了Klotho-Sirtuin1途径作为与年龄相关的心力衰竭的潜在治疗点.
科学领域:
- 心脏病学
- 老年学
- 分子生物学
背景情况:
- 衰老显著损害心脏功能,增加心力衰竭的患病率,特别是老年人中心力衰竭与保留射出分数 (HFpEF).
- 在老年人中,HFpEF是致病率和死亡率的主要原因,需要新的治疗策略.
- 抗衰老激素α-Klotho对心脏健康的作用是一个新兴的研究领域.
研究的目的:
- 调查可溶性Klotho (sKL) 在改善与年龄相关的心脏扩张功能方面的治疗潜力.
- 阐明sKL心脏保护作用的分子机制,重点关注Sirtuin1 (Sirt1) 途径.
- 评估sKL对心脏结构和老年心脏血管化的影响.
主要方法:
- 使用老化和克洛托缺乏的小鼠模型研究衰老对心脏功能的影响.
- 对老鼠模型进行可溶性Klotho (sKL) 补充.
- 评估心脏扩张功能,左心室缩,纤维化和毛细血管密度.
- 研究了Sirtuin1 (Sirt1) 在调解sKL对DNA损伤和蛋白质乙化的作用.
主要成果:
- 在老年小鼠中,补充可溶性Klotho (sKL) 显著改善了心脏扩张功能.
- sKL治疗导致左心室缩和心脏纤维化减少.
- 在老年心脏中,sKL的使用增加了毛细血管密度.
- sKL的心脏保护作用取决于Sirt1调节的DNA损伤途径和心脏蛋白质乙化.
结论:
- 针对Klotho- Sirtuin1轴对治疗与年龄相关的腹功能障碍和心力衰竭具有保留的喷射分数 (HFpEF) 的前景.
- 可溶性Klotho (sKL) 通过改善腹功能和心脏重塑,在老年心脏中表现出显著的心脏保护作用.
- 这些发现为治疗与衰老相关的心血管疾病提供了新的见解.
相关概念视频
Aging
179
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
179
The Effect of Aging on Tissues
2.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.4K
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Pathophysiology of Cardiac Performance
799
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
799
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505


